Brightwater Medical Expands IP Coverage of ConvertX Stent Family
May 15, 2018
Brightwater Medical announced today the issuance of U.S. Patent No 9,956,100 by the U.S. Patent and Trademark Office (USPTO) for the ConvertX Stent Family. This is the company’s third U.S. patent and strengthens their intellectual property (IP) position with additional claims. It builds on their foundational coverage of convertible catheters and stents.
Dedicated to a strong IP strategy, Brightwater’s growing patent portfolio now includes three (3) issued U.S. patents and twelve pending patents, four (4) of which are in the U.S. and eight (8) international.